Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类]
[关键词] SYSTEMIC EMBOLISM;OUTCOMES [时效性]
